Neurable

Other Devices and Supplies · Boston, MA · Founded 2015 · Privately Held (backing)

Developer of brain-computer interfaces designed to translate brain activity into actionable insights. Neurable is based in Boston, MA and was founded in 2015. Its last reported valuation was $23.5 million in Dec 2019. It has raised $63.9 million across 3 recorded rounds; the latest was a $13 million later-stage round in May 2024.

Last reported valuation
$23.5M
Oct 2026
Priced at
—
Total raised
$63.9M
Last round
Later Stage VC
May 2024

Neurable key facts

as of Oct 2026
  • Developer of brain-computer interfaces designed to translate brain activity into actionable insights.
  • Neurable is valued at approximately $23.5M as of Oct 2026 (last reported valuation).
  • It has raised $63.9M across 3 recorded rounds; the latest was Later Stage VC ($13.0M) in May 2024.
  • Notable investors include US National Science Foundation, Global Brain, Metaplanet Holdings, Capital Factory, FundersClub — 43 tracked in total.
  • 2 investment vehicles were formed to buy Neurable shares in the last 12 months, reporting $680K sold to 50 investors, per SEC Form D filings.
  • Neurable has filed 3 Form Ds with the SEC since 2018, most recently Dec 2019 ($5.7M sold to 12 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$23.5M

Neurable's last reported valuation, Dec 2019. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Neurable with a free account
  • ·The complete investor list: 43 names
  • ·Watch Neurable: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Neurable funding rounds

3 rounds
May 2024Later Stage VC$13.0M▮
Apr 2019Early Stage VC (Series A)$1.0M▮
Mar 2018Seed Round$4.9MSEC filing▮

Vehicles formed to buy Neurable shares

secondary demand · SEC Form D filings

In the last 12 months, 2 investment vehicles were formed to buy Neurable shares, reporting $680K sold to 50 investors across 2 sponsors. Most recent filing Oct 2025.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 2 vehicles →

Membership and data by Private Market View

Neurable valuation

Neurable's last reported valuation was $23.5 million in Dec 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Neurable raised?

Neurable has raised $63.9 million in total; 3 of its rounds are on record, from 2018 on. The largest on record was a $4.9 million seed round in Mar 2018; the most recent was a $13 million later-stage round in May 2024.

Neurable has filed 3 Form Ds with the SEC since 2018, most recently in Dec 2019 ($5.7 million sold to 12 investors).

Institutional holders and vehicles

In the last 12 months, 2 investment vehicles were formed to buy Neurable shares, reporting $680,230 sold to 50 investors across 2 sponsors, per SEC Form D filings (most recent Oct 2025).

Neurable investors

43 investors are on record for Neurable, including US National Science Foundation, Global Brain, Metaplanet Holdings and Capital Factory. By type, the record holds 13 venture capital firms and 2 hedge funds. The later-stage round in May 2024 drew 10 investors.

Comparable companies

Comparable other devices and supplies names by valuation on PrivateMarketView: Cytrellis ($38.1 million) and Wicked Sheets ($7.1 million).

About Neurable

Developer of brain-computer interfaces designed to translate brain activity into actionable insights. The company's software incorporates neuroscience, biology, statistics, machine learning, and design, enabling clients to control software and devices using only their brain activity.

Industry
Other Devices and Supplies
Sector
Healthcare
HQ
Boston, MA, United States
Founded
2015
Employees
35
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.